Pegylated interferon-alfa-2a

DRUG2 trials

Sponsors

Chinese University of Hong Kong, Eiger BioPharmaceuticals

Conditions

Chronic Hepatitis BChronic Hepatitis D Infection

Phase 2

Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)

CompletedNCT02430194

Eiger BioPharmaceuticalsChronic Hepatitis D Infection

Start: 2014-12-31End: 2017-06-15Updated: 2023-03-03

Phase 4

Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

CompletedNCT00226382

Chinese University of Hong KongChronic Hepatitis B

Start: 2005-01-31End: 2008-04-30Updated: 2010-06-11